Can Gene Expression Predict if a Brain Tumor Is Likely to Grow Back?
A gene expression test can accurately predict the best treatment for meningioma patients by measuring the aggressiveness of their tumors and adjusting treatment accordingly.
University of California San Francisco
Give to UCSFA gene expression test can accurately predict the best treatment for meningioma patients by measuring the aggressiveness of their tumors and adjusting treatment accordingly.
UCSF Chancellor Sam Hawgood’s 10th State of the University address will feature a first-ever AI panel discussion with experts Atul Butte, MD, PhD, and Sara Murray, MD, MAS
A collaboration is between two biomedical researchers bridges the laboratory and clinic to advance the science of itch, allergy and asthma.
UCSF Benioff Children’s Hospital Oakland used innovative 3D imaging during surgery to help correct a scoliosis patient's curved spine.
A phase 1 trial shows promise in treating metastatic prostate cancer with a single priming dose of radioligand therapy and immunotherapy.
UCSF's Adam Boxer, MD, PhD, and Harvard neurologist Reisa Sperling, MD, review the history of clinical trials over the past 30 years in Alzheimer’s research with what was learned and how new biomarkers and clinical trial approaches are being used to find more effective treatments in a more efficient way than in the past.
UCSF researchers developed a new neighborhood-based model of care that brings medicine to people immediately after being diagnosed with hepatitis C.
A study found that children who were recently diagnosed with type 1 diabetes need less supplemental insulin to keep their blood sugar in a healthy range if they use the immunotherapy drug teplizumab.
UCSF experts to discuss amyloid therapies and dementia research at CTAD conference, addressing equity, novel treatments, and innovative studies.
Scientists found that the nervous system tamps down allergic response, which could change how asthma, Crohn’s and other inflammatory diseases are treated.
UCSF Health was named among the nation’s “Most Wired” hospitals, an award that recognizes UCSF Health’s commitment to being on the cutting edge of digital health and health information technology.
A new study will combine an Alzheimer’s medication that slows disease progression in some patients with two other drugs to see if their effects can be amplified.